title: Is There a Future for Interleukin 17 Blocking Agents in Rheumatoid Arthritis?
authors.affiliation: Pôle de pathologies rhumatismales, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain; and Department of Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium. Patrick.Durez@uclouvain.be.
authors.forename: Patrick
authors.initials: P
authors.lastname: Durez
mesh_terms: D000818:Animals; D001172:Arthritis, Rheumatoid / Q000276:immunology*; D006801:Humans; D007249:Inflammation / Q000276:immunology*; D020381:Interleukin-17 / Q000276:immunology*
chemical_list: D020381:Interleukin-17